These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26077351)

  • 1. Interventional Management of Unprotected Left Main Coronary Artery Disease: Patient Selection and Technique Optimization.
    Rizik DG; Klassen KJ; Burke RF; Hodgson JM; Stone GW
    J Interv Cardiol; 2015 Aug; 28(4):326-38. PubMed ID: 26077351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.
    Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28607000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention as an alternative to bypass surgery for unprotected LMCA stenosis.
    Park SJ; Kim YH
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1107-14. PubMed ID: 18793113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient selection and percutaneous technique of unprotected left main revascularization.
    Testa L; Latib A; Bollati M; Bedogni F
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):637-643. PubMed ID: 29521440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents in unprotected left main coronary artery disease.
    Bernelli C
    Expert Rev Cardiovasc Ther; 2014 Nov; 12(11):1349-68. PubMed ID: 25340285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous coronary intervention of unprotected left main coronary artery disease: procedural strategies and technical considerations.
    Lee MS; Stone GW; Park SJ; Teirstein P; Moses J; Colombo A; Kandzari DE
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):812-22. PubMed ID: 21793172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Main Disease: What Is the Correct Approach to Revascularization?
    Rab T; King SB
    Cardiol Rev; 2018; 26(5):219-229. PubMed ID: 29794807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous revascularization of left main: role of imaging, techniques, and adjunct pharmacology.
    Palmerini T; Alessi L; Rizzo N; Dangas G
    Catheter Cardiovasc Interv; 2012 May; 79(6):990-9. PubMed ID: 21805577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease.
    Naqvi SY; Klein J; Saha T; McCormick DJ; Goldberg S
    Am J Cardiol; 2017 Feb; 119(4):520-527. PubMed ID: 28012553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very long-term outcomes following drug-eluting stent implantation for unprotected left main coronary artery stenosis: a single center experience.
    Ielasi A; Latib A; Chieffo A; Takagi K; Mussardo M; Davidavicius G; Godino C; Carlino M; Montorfano M; Colombo A
    Rev Esp Cardiol (Engl Ed); 2013 Jan; 66(1):24-33. PubMed ID: 23041167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.
    Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
    Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
    Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of left main coronary artery disease.
    Fajadet J; Chieffo A
    Eur Heart J; 2012 Jan; 33(1):36-50b. PubMed ID: 22210689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous revascularization of unprotected left main: results of PCI using drug-eluting stent in ostial versus distal bifurcation disease.
    Al Rashdan I; Amin H
    Angiology; 2010; 61(1):19-23. PubMed ID: 19398419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry).
    Buchanan GL; Chieffo A; Meliga E; Mehran R; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Narbute I; Makkar RR; Palacios IF; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Allgar V; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    Am J Cardiol; 2014 Apr; 113(8):1348-55. PubMed ID: 24581924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Contemporary Management of Left Main Coronary Artery Disease.
    Mailey JA; Spence MS
    Curr Cardiol Rev; 2022; 18(1):e170621194128. PubMed ID: 34139985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
    Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.
    Ahn JM; Roh JH; Kim YH; Park DW; Yun SC; Lee PH; Chang M; Park HW; Lee SW; Lee CW; Park SW; Choo SJ; Chung C; Lee J; Lim DS; Rha SW; Lee SG; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ
    J Am Coll Cardiol; 2015 May; 65(20):2198-206. PubMed ID: 25787197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.